Search
for
Sort by
Research 241–270 of 1000+
- Ablative 2940-nm Er: YAG fractional laser for the treatment of male androgenetic alopecia with predominantly frontal hairline recession
- Feasibility and tolerability of eribulin-based chemotherapy versus other chemotherapy regimens for patients with metastatic triple-negative breast cancer: a single-centre retrospective study
- Topical 5% minoxidil versus combined erbium YAG laser and topical 5% minoxidil in androgenetic alopecia: A randomized controlled trial
- Non-ablative Er:YAG-laser treatment improves quality of life in menopausal female pattern hair loss
- Expression of collagen type I, skin fibroblasts and macrophages after 1550 nm erbium glass fractional laser in androgenic alopecia
- Dihydrotestosterone Induces Keratinocyte Apoptosis by Activating ERK Signaling
- Ergothioneine, collagen peptides, and sodium hyaluronate ameliorate facial skin aging via modulating oxidative stress, inflammation, and extracellular matrix homeostasis
- Erythema Centrifugum: The Unexpected Hidden Cause
- Erythema Centrifugum: The Unexpected Hidden Cause
- Nanoparticle-enhanced plant extracts and erythropoietin analogues for treating third-degree burns in rats: A systematic review of regenerative therapeutic strategies
- BH20 An unintended sequela of hair regrowth: severe Janus kinase inhibitor-associated acneiform eruption in alopecia areata
- Cutaneous gain-of-function mutation of LRIG3 leads to alopecia by upregulation of ERBB, PI3K/AKT, NOTCH1 signaling pathways
- Erythromelanosis Follicularis Faciei et Colli: A Case Report
- IP28-24 RISK OF ERECTILE DYSFUNCTION AMONG REPRODUCTIVE-AGED MEN FOLLOWING LOW-DOSE FINASTERIDE USE FOR ANDROGENETIC ALOPECIA: A PROPENSITY-MATCHED COHORT STUDY
- Population-level risk of erectile dysfunction after finasteride use for androgenetic alopecia: a national cohort analysis
- Hair Growth–Promoting Activity of Flavone-Rich Fractions Derived from Eremochloa ophiuroides extracts
- All Subcomponents of the Cutaneous Lupus Erythematosus Disease Area and Severity Index–Activity (CLASI-A) are Relevant to Identify and Detect Changes in Skin Activity
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- Clinical Spectrum of Cutaneous, Ocular, and Hair Manifestations in Patients With Inborn Errors of Immunity: Insights From a Single Center in Turkey
- The mechanistic insights into the application of retinoids and possible adjunct therapeutic treatment to androgenic alopecia: Erratum
- Erthwellness Discount Code "AVA25" Get 25% Off On All Products!
- Erthwellness Discount Code "AVA25" Get 25% Off On All Products!
- Erosive Pustular Dermatosis of the Scalp Due to Afatinib: A Rare Case
- Erratum: Unmasking Lichen Planopilaris in the Shadow of Female Pattern Hair Loss: A Diagnostic Pitfall
- Treatment and Long-Term Outcome of COVID-19 Disease in Children with Inborn Errors of Immunity (IEI): Does Hematopoietic Stem Cell Transplantation (HSCT) Have a Protective Effect?
- Erosive palmoplantar lichen planus: clinical and histopathological insights from an ethnic population of North-East India
- Commentary: Erythrasma Capitis and Hair Loss – An Under Diagnosed Entity?
- Extraction Videodermoscopy of Eruptive Vellus Hair Cyst
- Erythroderma, Alopecia, Anhidrosis, and Vitiligo as Complications of a Red Ink Tattoo—A Case Report
- Widespread erythematous scaly eruption in an infant with phenylketonuria